SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-07-246931
Filing Date
2007-11-14
Accepted
2007-11-14 13:14:29
Documents
8
Period of Report
2007-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 442684
2 BINDING LETTER OF INTENT dex101.htm EX-10.1 33489
3 LICENSE AGREEMENT dex102.htm EX-10.2 114582
4 SUPPLY AGREEMENT dex103.htm EX-10.3 89236
5 CONSENT TO ASSIGNMENT AND GUARANTEE OF LICENSE AND SUPPLY AGREEMENTS dex104.htm EX-10.4 15313
6 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9286
7 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9257
8 SECTION 906 CEO AND CFO CERTIFICATION dex321.htm EX-32.1 4696
  Complete submission text file 0001193125-07-246931.txt   719959
Mailing Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 071242732
SIC: 2836 Biological Products, (No Diagnostic Substances)